Intravitreal ganciclovir for neonatal cytomegalovirus-associated retinitis: a case report

A Oschman1, V Murthy, R Kollipara

  • 1Department of Pharmacy, Children's Mercy Hospital and Clinics, Kansas City, MO 64108, USA. aoschman@cmh.edu

Insights

Congenital cytomegalovirus (CMV) retinitis can cause vision loss in newborns. This case study shows intravitreal ganciclovir may be a safe and effective treatment option for neonates with this condition.

Area of Science:

  • Ophthalmology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Congenital cytomegalovirus (CMV) infection is a leading cause of congenital disabilities.
  • CMV retinitis (CMVR) affects a significant percentage of infants with congenital CMV.
  • Intravitreal ganciclovir is a standard treatment for CMVR in adults but its use in neonates is not documented.

Observation:

  • A case report of a term neonate diagnosed with CMVR.
  • The neonate received both intravenous and intravitreal ganciclovir.
  • Three doses of intravitreal ganciclovir (2 mg per eye) were administered.

Findings:

  • Intravitreal ganciclovir treatment was well-tolerated in the neonate.
  • Improvement in the infant's retinitis was observed following treatment.
  • This suggests intravitreal ganciclovir may be effective for treating CMVR in neonates.

Implications:

  • This case suggests a potential new treatment approach for CMVR in neonates.
  • Further research is warranted to confirm the efficacy and safety of intravitreal ganciclovir in this population.
  • This could lead to improved visual outcomes for infants with congenital CMV infection.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...